Hexagon Nutrition board meet 30 Sep 2026: agenda details
Ask Iris
Stock snapshot and why the meeting matters
Hexagon Nutrition Ltd (INE0JUI01012) was trading at ₹67.99 as of 30 Sept 2026 at 11:16, valuing the company at a market capitalisation of ₹796.76 crore. The company has scheduled a board meeting on September 30, 2026 to consider corporate governance matters tied to board leadership and executive remuneration. The meeting follows requisitions from promoter-shareholder groups seeking board-level action and an Extraordinary General Meeting (EGM). Such requisitions typically draw investor attention because they can shape control, oversight, and pay governance at the company.
Board meeting intimation and compliance framework
Hexagon Nutrition informed exchanges about the board meeting under Regulation 29 of the SEBI (Listing Obligations and Disclosure Requirements) Regulations, 2015. The stated purpose includes considering “other business matters”, alongside specific items linked to director appointment and remuneration approval. Exchange communication also referenced the meeting being broadcast on 26-Sep-2026 with timestamps shown as 21:43:42 and 21:32:33 in the available disclosure trail. The company indicated that further details would be made available on its official website.
First requisition: proposal to appoint Arun Purushottam Kelkar
The board is set to take note of a requisition letter dated September 24, 2026, submitted under Section 100(2) of the Companies Act, 2013. The requisition is stated to be from Dr. Nikhil Arun Kelkar and Mr. Vikram Arun Kelkar, described as promoters and shareholders holding a combined 38.41% of Hexagon Nutrition’s shareholding. Their request seeks the appointment of Mr. Arun Purushottam Kelkar (DIN: 00171276) as Executive Director and Chairman. The proposal is linked to a notice of candidature received under Section 160(1) of the Companies Act, 2013.
Pay approval request for Arun Purushottam Kelkar and EGM proposal
Along with the appointment request, the requisition asks the board to consider approving the remuneration payable to Arun Purushottam Kelkar for his term. It also seeks that the company convene an Extra-ordinary General Meeting (EGM) to obtain shareholder approval for these matters. The board meeting agenda, as described, is to review and take note of the requisition and then decide on subsequent corporate actions, including whether to call an EGM. The company also noted that the board may consider and transact other business as decided by the chairperson with the consent of the board.
Second requisition: remuneration approval for Managing Director Vikram Kelkar
A separate requisition dated September 24, 2026 has also been placed before the board. This request is stated to be submitted by Dr. Nikhil Arun Kelkar and Ms. Anuradha Kelkar, described as shareholders and promoter members holding a combined 24.67% of the shareholding. They have asked for approval of remuneration payable to Mr. Vikram Kelkar, the company’s Managing Director (DIN: 02302364), with effect from April 1, 2026. Similar to the first requisition, this group has also called for an EGM to address the requested approvals.
Promoter ownership context and SAST disclosure reference
As of 30 June 2026, the promoter holding in Hexagon Nutrition was reported at 64.29%, with 0.0% pledged. The company also stated it enclosed a disclosure under Regulation 29(2) of SEBI (Substantial Acquisition of Shares and Takeovers) Regulations, 2011 for Vikram Kelkar. The article context does not provide transaction quantities or timelines for the SAST disclosure, but it signals that exchange-facing compliance disclosures are active around promoter or insider holdings.
Recent AGM actions and dividend trail
Hexagon Nutrition held its 33rd Annual General Meeting on September 22, 2026 through video conference/remote e-voting arrangements, as referenced in the company’s communications. Shareholders approved the appointment of Raghunath Sawant as Executive Director and the re-appointment of Nikhil Kelkar as Joint Managing Director at that AGM. The company also referenced a final dividend of ₹0.30 per share, with the dividend item appearing as 15Sep Dividend Final ₹0.30 per share in the 2026 event trail.
Prior board changes and resignations
The company earlier accepted resignations of Executive Director Subhash Purushottam Kelkar and Non-Executive Director Aditya Kelkar from its board, effective July 6, 2026. The resignations were reported as following the complete divestment of their shareholding in the company. This background adds context to why the September 30 board agenda is being watched closely, given the governance and leadership items now placed before the board by promoter groups.
Key facts at a glance
Timeline of disclosed meetings and events (from available trail)
Market impact and governance significance
The immediate market reference point is the stock trading near ₹67.99 with a market cap of ₹796.76 crore as the board convenes. The agenda items are governance-led, focusing on board leadership structure and remuneration approvals, rather than operational guidance or financial projections. The requisitions cite specific provisions of the Companies Act for shareholder-led requests, indicating a formal process route for governance changes. Investors typically track whether such board deliberations lead to an EGM, since that can shift the decision to shareholders and provide clarity on the company’s leadership roadmap. At the same time, the reported promoter holding of 64.29% (with no pledge) provides context on voting influence, without implying outcomes.
Conclusion
Hexagon Nutrition’s September 30, 2026 board meeting is set to consider promoter requisitions covering an Executive Director and Chairman appointment and approval of Managing Director remuneration effective April 1, 2026. The company has also recently completed its 33rd AGM and referenced a ₹0.30 per share final dividend. Any next steps such as convening an EGM would depend on what the board decides after taking note of the requisitions and related statutory requirements, as outlined in the meeting agenda.
Frequently Asked Questions
Did your stocks survive the war?
See what broke. See what stood.
Live Q2 Earnings Tracker
